Patents Assigned to SNAKEPHARM ENTERPRISES, LLC
  • Patent number: 11129857
    Abstract: Disclosed herein are compositions and methods for treating a victim of a venomous snakebite. Antivenom compositions are prepared from snake plasma or from snake eggs. The antivenom compositions are able to neutralize a snake venom from an autologous snake. The antivenom compositions can be administered to a snakebite victim to treat or prevent the pathological effects of a venomous snakebite.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: September 28, 2021
    Assignee: SNAKEPHARM ENTERPRISES, LLC
    Inventor: Donald Schultz